GPS Wealth Strategies Group’s Takeda Pharmaceutical TAK Stock Holding History

GPS Wealth Strategies Group’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-19	Closed	-$278	–	1464
2025 Q3	$278	Hold	19	–	–	﹤0.01%	1564
2025 Q2	$294	Buy	19 +13	+217%	+$192	﹤0.01%	1525
2025 Q1	$89	Buy	+6	New	+$84	﹤0.01%	1462
2022 Q4	–	Sell	-1,510	Closed	-$20K	–	971
2022 Q3	$20K	Hold	1,510	–	–	0.01%	622
2022 Q2	$21K	Hold	1,510	–	–	0.01%	614
2022 Q1	$22K	Buy	+1,510	New	+$22.2K	0.01%	577
2021 Q4	–	Sell	-200	Closed	-$3K	–	1106
2021 Q3	$3K	Hold	200	–	–	﹤0.01%	920
2021 Q2	$3K	Hold	200	–	–	﹤0.01%	938
2021 Q1	$3K	Buy	+200	New	+$3.6K	﹤0.01%	837

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

GPS Wealth Strategies Group's TAK Position: Q4 2025 in Review

GPS Wealth Strategies Group sold out of Takeda Pharmaceutical (TAK) in Q4 2025, closing a stake of 19 shares — an estimated $278 sold.

GPS Wealth Strategies Group first reported a position in TAK in Q1 2021 and held it in 9 quarters. The position peaked at $22K in Q1 2022. 349 funds tracked by Wall St. Rank hold TAK as of Q4 2025.

GPS Wealth Strategies Group reported no remaining Takeda Pharmaceutical position as of Q4 2025 after selling out during the quarter.
GPS Wealth Strategies Group sold 19 Takeda Pharmaceutical shares in Q4 2025, an estimated $278.
GPS Wealth Strategies Group first reported a position in Takeda Pharmaceutical in Q1 2021 and held it in 9 quarters.
GPS Wealth Strategies Group's Takeda Pharmaceutical position peaked at $22K in Q1 2022.
349 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.